Publication Type:

Journal Article

Source:

International Journal of Pharmaceutical Sciences Review and Research, Volume 6, Number 1, p.55-59 (2011)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-79952044224&partnerID=40&md5=2dd6f95fad35fc1ad0e019906922cb07

Keywords:

article, clinical article, cost of illness, disease severity, drug cost, female, gastrointestinal symptom, health disparity, hospital cost, human, hyperglycemia, male, medical fee, neuroleptic agent, obesity, schizophrenia, side effect, tertiary health care, weight gain

Abstract:

The study deals with the pharmacoeconomic aspect of Schizophrenia. Schizophrenia is disabling group of brain and behavioral disorders and in this study the cost of illness of schizophrenia has been in calculated with a special consideration to the cost of drugs prescribed for the treatment. The study has been conducted in a tertiary care super-specialty hospital of Kerela, India. The participants of the study are patient having an acute episode of schizophrenia and who have admitted for the treatment of the same. An attempt has been made to find the direct cost incurred for the treatment of schizophrenia - an acute episode and study the various aspects related to it like the disparity of cost in males and females and variability in the cost due to the varied symptoms of the disorder. In the study it has been observed that the cost of drugs contributes a significantly less amount in the total cost of treatment of the disorder. Also, it has been observed that apart from the severity of symptoms a major impact factor on the cost of the drug are adverse effects associated with the antipsychotic treatment.

Notes:

cited By (since 1996)1

Cite this Research Publication

S. Pahuja, Aboobacker, S., and Shini, V. K., “Schizophrenia - Cost of illness”, International Journal of Pharmaceutical Sciences Review and Research, vol. 6, pp. 55-59, 2011.